Discover
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML
A recent case report describes a patient with relapsed AML harboring IDH1 and NPM1 co-mutations who achieved a durable, treatment-free remission with single-agent olutasidenib.
January 29, 2026
Functional, Fast, and Unbiased TCR Discovery with Bruker’s Optofluidic Platform
Identifying antigen specific T-cell receptors (TCRs) is critical for advancing TCR-T therapies, vaccines, and infectious disease research. Yet, traditional peptide-MHC tetramer/dextramer sorting only tells part of the story.
January 23, 2026
Development of new albumin‑binding radiotracers for PET imaging of CSF
In this study by Peltoniemi et al., PET/CT imaging using the X-CUBE (CT) and ß-CUBE (PET) was used to non-invasively visualize cerebrospinal fluid (CSF) flow and glymphatic system dynamics in rats.
November 28, 2025
Introducing Cytek Aurora Evo – The New Standard for Full Spectrum Cytometry
Join OMIXYS for this educational webinar in cooperation with Cytek. The Cytek Aurora Evo system delivers the same high-performance fluorescence capabilities as its predecessors, now enhanced with new features designed to meet the evolving demands.
November 20, 2025
The real-time PCR thermal cycler qTOWER iris empowers your exploration
3D Model- Embark on the qTOWER iris Interactive Experience. Navigate via click-and-drag through the 3D model of the qTOWER iris System and delve into its features. Select the red markers to unveil insights into key features.
October 30, 2025
Can you solve mouse CT imaging with 50um spatial resolution ?
MOLECUBES, a Bruker Company offers small footprint microCT for mice and rats, which meets most of your needs for in-vivo analysis and doesn't sacrifice the budget.
October 22, 2025
Combination of low-energy X-ray & citric acid to inactivate E.coli, S.Typhimurium, L.Monocitogenes
Combined treatment with 0.5 kGy X-ray and 0.1 % CA significantly decreased biofilm cell counts by 5.10, 4.31, and 3.96 log CFU/coupon for E. coli O157:H7, S. Typhimurium, and L. Monocytogenes, respectively.
December 3, 2025
Genotype-Specific Macrophage Programs in the NSCLC Microenvironment
Understanding cell-cell interactions within the tumor-immune microenvironment is crucial for advancing cancer therapies. Macrophages show highly variable roles in tumor progression and response, yet the drivers of this complexity remain unclear.
November 26, 2025
Advances in Biofilm Research: How the Experts are Overcoming Obstacles
There are plenty of areas of interest when working with biofilms. In this article we focus on two major ones: biofilm drug resistance and antibiofilm drug development and the approach one can take in research.
November 19, 2025
Introducing EOS6: High content – live cell analysis inside your incubator
Built to support multiple users and applications, the EOS6 can run up to six microplates in parallel, flask, dishes, slides… Users can schedule experiments at different image acquisition frequencies and magnifications in parallel.
October 24, 2025
Elevating Intravital Imaging with AI: Introducing the AI-Image Denoiser
AI-Image Denoiser, our best-in-class, AI-powered image enhancement software designed specifically for high-speed intravital microscopy.
October 21, 2025
The Path to Clinical Relevance: Moving from Spatial Transcriptomics to Protein Profiling
Spatial biology is a rapidly evolving discipline that advances human health by leveraging imaging technologies. It encompasses research activities ranging from whole-transcriptome profiling to clinically impactful single-protein biomarker tests.
December 2, 2025
Perfusion: The Beating Heart of Single-Cell Biology and Cancer Immunotherapy
Single-cell biology has transformed our ability to uncover cellular diversity and dynamic behavior within complex tissues that are otherwise masked in population-level analyses.
November 24, 2025
Preclinical Development for Therapy of Hard-to-Treat PD-L1-Positive Solid Tumors
They developed MDG1015 — CD8⁺ TCR-T cells armored with a PD1-41BB costimulatory switch protein (CSP) that converts PD-L1–mediated inhibition into activation. In vitro, they selectively kill PD-L1⁺ tumor cells while sparing non-target cells.
November 17, 2025
Reanalyze your in-vivo optical images with Aura Software
Aura is a free license software application produced by Spectral Instruments Imaging, a Bruker Company.
October 23, 2025